SAGES 2010: Barrett's Esophagus Still a Conundrum for Surgeons
Executive Summary
At the recent 12th World Congress of Endoscopic Surgery, hosted by the Society of American Gastrointestinal and Endoscopic Surgeons, physicians discussed the challenges of identifying patients at risk of esophageal cancer. Barrett’s esophagus has long been known as a risk factor, but it remains a mystery as to how to predict which patients with Barrett’s will progress to esophageal cancer and who to screen in order to prevent it,
You may also be interested in...
GI Endoscopy: Thriving on Innovation
Growth in the gastrointestinal endoscopy products market is being driven by advancements in GI diagnostics and screening technologies and growing adoption of high definition cameras and other enhanced imaging tools designed to improve diagnostic sensitivity and specificity in vivo, decrease the number of unnecessary procedures, and improve patient outcomes. Looking to the future, technological innovation will continue to impact growth in this market as emerging minimally invasive devices help redefine the diagnosis and treatment of GI disorders.
GI Endoscopy: Thriving on Innovation
Growth in the gastrointestinal endoscopy products market is being driven by advancements in GI diagnostics and screening technologies and growing adoption of high definition cameras and other enhanced imaging tools designed to improve diagnostic sensitivity and specificity in vivo, decrease the number of unnecessary procedures, and improve patient outcomes. Looking to the future, technological innovation will continue to impact growth in this market as emerging minimally invasive devices help redefine the diagnosis and treatment of GI disorders.
New Developments in Obesity Intervention
With soaring medical costs weighing heavily on the US economy, it's not surprising that obesity has become a target in the health care reform debate. Obesity is costly because it significantly increases the risk of many chronic diseases. Exercise, dieting and prescription drugs have had a limited effect in stemming the tide of obesity, leaving bariatric surgery and other interventional techniques as the primary treatment options for this potentially multi-billion dollar market. But device manufacturers have a challenge ahead of them--to develop more effective, safer, and less invasive obesity therapies that will not only result in long-term weight loss, but will also cut treatment costs and better manage comorbidities.